AFT Pharmaceuticals has recently announced for the first time their breakthrough Nasal Drug Delivery Device that they have been developing with IDA and various technology partners. The device is unique in that it can deliver medication to the nasal cavity at a high rate and has a performance far exceeding current market offerings. During the 4 year development program, IDA was responsible for the industrial and mechanical design of the device, design documentation, as well as performing initial scoping studies and proof-of-concept prototyping.

 The device is currently being tooled overseas and is expected to undergo clinical trials shortly. You can read more about the product at: